
CatSci further strengthens its customer-focused Strategic Advisory Board with three key appointments
11 November 2020 - Cardiff, UK
Cardiff, UK - CatSci, a scientifically led, commercially minded and award-winning innovation partner, has appointed three key industry thought leaders to its Strategic Advisory Board (SAB), Dr Rob Harris, Kate Smith and Dr Robert Dennehy.
Learn more
CatSci partners with three leading UK organisations to offer expert support across the pharmaceutical supply chain
21 October 2020 - Cardiff, UK
CatSci Ltd today announced partnerships with three UK companies across the pharmaceutical supply chain – M2M Pharmaceuticals (M2M Pharma), New Path Molecular (NPM) and Upperton Pharma Solutions (Upperton). This will provide CatSci’s customers with access to specialised capabilities and expertise, ensuring they can develop affordable, best-in-class small molecule therapeutics that meet their evolving healthcare needs.
Learn more
Chemical Development in Pharma: A CatSci Virtual Symposium
15 October 2020
We are delighted to be hosting a free virtual half-day symposium that is open to all. We want our event to bring the chemistry community together from young scientists to industrial experts across the globe to discuss the latest developments in process research and development. Sign up using the link below!
Register Now
CatSci makes new appointments to its Board to further continue strategic growth
15 September 2020 - Cardiff, UK
CatSci Ltd, a scientifically led, commercially minded and award-winning innovation partner, has announced the appointment of Gary Lumby, MBE FCIOBS, and Stephanie Knowles as Non-Executive Director (NED) and Financial Director, respectively.
Learn more